Specialty CDMO HAS Synthesis, the US division of HAS Healthcare Advanced Synthesis (formerly Helsinn) is located in Switzerland.
Below are a few HAS highlights.
• Established in 1984 as a full service CDMO with focus on small molecule API, HPAPI, and Anticancer compounds.
• Formerly Helsinn Advanced Synthesis based out of Biasca, Switzerland, becoming a stand-alone organization known as HAS Healthcare and HAS Synthesis (US).
• Offering a full range of services including process development / optimization, scale up, tech transfer, analytical, and regulatory support.
• New growth by investing in a new QC Lab Center (now fully active) as well as new production HPAPI suites to add to our existing capacity.
• A strong commitment to safety and environmental sustainability.
We look forward to connecting soon, better presenting our capabilities, and learning more about your small molecule compound(s) of interest to see if there is an opportunity to partner together in the future.